Galmed Pharmaceuticals Ltd. reported a net loss of approximately $3.6 million for the six months ended June 30, 2025, compared to a loss of $2.4 million for the same period in 2024. As of June 30, 2025, the company's total assets were $22.9 million and it had cash and equivalents of $5.0 million.